Society guideline links: Inherited arrhythmia syndromes

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Arrhythmias in adults" and "Society guideline links: Ventricular arrhythmias".)

International

●Heart Rhythm Society (HRS): Expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy (2019)

●HRS/European Hearth Rhythm Association (EHRA)/Asia Pacific Heart Rhythm Society (APHRS)/Latin America Heart Rhythm Society (LAHRS): Expert consensus statement on catheter ablation of ventricular arrhythmias (2019)

●HRS/EHRA/APHRS: Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes (2013)

Canada

●Canadian Cardiovascular Society (CCS)/Canadian Heart Rhythm Society (CHRS): Implantable cardioverter-defibrillator guidelines, 2016 (published 2017)

●CCS/CHRS: Society position statement on recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death (2011)

United States

●American Heart Association (AHA): Scientific statement on genetic testing for inherited cardiovascular diseases (2020)

●American College of Cardiology (ACC)/AHA/Heart Rhythm Society (HRS): Guideline for the evaluation and management of patients with syncope (2017)

●AHA/ACC/HRS: Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2017)

●AHA: Science advisory on wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death (2016)

●AHA: Scientific statement on electrocardiographic early repolarization (2016)

●AHA/ACC: Scientific statement on eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities – Arrhythmias and conduction defects (2015)

●American College of Cardiology Foundation (ACCF)/HRS/AHA/American Society of Echocardiography (ASE)/Heart Failure Society of America (HFSA)/Society for Cardiovascular Angiography and Interventions (SCAI)/Society of Cardiovascular Computed Tomography (SCCT)/Society for Cardiovascular Magnetic Resonance (SCMR): Appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy (2013)

Europe

●European Society of Cardiology (ESC): Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2022)

●European Heart Rhythm Association (EHRA): Consensus document on the management of asymptomatic arrhythmias (2019)

●Heart Rhythm Society (HRS)/EHRA/Asia Pacific Heart Rhythm Society (APHRS)/Latin America Heart Rhythm Society (LAHRS): Expert consensus statement on catheter ablation of ventricular arrhythmias (2019)

●EHRA, Association for European Paediatric and Congenital Cardiology (AEPC), and ESC: Position paper on arrhythmias in congenital heart disease (2018)

●ESC: Clinical practice guidelines for the diagnosis and management of syncope (2018)

●EHRA and the European Association for Cardiovascular Prevention and Rehabilitation (EACPR): Position paper on pre-participation cardiovascular evaluation for athletic participants to prevent sudden death (2017)

●HRS/EHRA/APHRS: Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes (2013)

●EHRA: A position paper on management of patients with palpitations (2011)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death (2017)

●NICE: Clinical guideline on transient loss of consciousness ('blackouts') in over 16s (2010, updated 2014)

●NICE: Quality standard on transient loss of consciousness ('blackouts') in over 16s (2014)

●Heart Rhythm UK: Position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes (2010)

Australia–New Zealand

●Cardiac Society of Australia and New Zealand (CSANZ): Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia (CPVT) (2016)

●CSANZ: Position statement on the diagnosis and management of familial long QT syndrome, update (2016)

●Australian Resuscitation Council (ARC): Guideline on managing acute dysrhythmias (2009)

Japan

●[In Japanese] Japanese Circulation Society (JCS)/Japanese Heart Rhythm Society (JHRS): Guideline on non-pharmacotherapy of cardiac arrhythmias, focused update (2021)

•[In Japanese] JCS: Guideline on non-pharmacotherapy of cardiac arrhythmias (2018)

●[In Japanese] JCS: Guidelines for diagnosis and management of inherited arrhythmias (2017)